Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Changsha,Hunan,China

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Asia

  • Sample Provided: no

    Payment Terms: L/L

    Huateng Pharmaceutical, a global supplier of pharmaceutical intermediates, offers Favipiravir intermediates 6-Bromo-3-hydroxypyrazine-2-carboxamide (CAS NO. 259793-88-9) for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation

    Favipiravir, also known as T-705 or Avigan, is an antiviral drug being developed by Toyama Chemical (Fujifilm group) of Japan with activity against many RNA viruses. In February 2020 Favipiravir was being studied in China for experimental treatment of the emergent COVID-19 (novel coronavirus) disease.

Send your message to this supplier
  • From:
  • To:
    Hunan HuaTeng Pharmaceutical Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service